Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses
- PMID: 7586979
- DOI: 10.1007/BF02207676
Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses
Abstract
To estimate the complement-activating property (CAP) of IgM rheumatoid factor (RF), which was purified from synovial fluids of patients with rheumatoid arthritis, in a reaction with each IgG subclass, the activation and binding of C4 in the classical pathway of complement by IgM RF was measured in an enzyme-linked immunosorbent assay using biotinylated F(ab')2 antibody to human C4. The CAP of IgM RF reacting with IgG3 was significantly higher than that of IgM RFs bound to the other IgG subclasses (P < 0.01). These results suggest that IgM RF reacting with IgG3 in synovial fluid could induce a greater degree of complement-dependent inflammation in RA synovium than IgM RF reacting with other IgG subclasses.
Similar articles
-
Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors.Ann Rheum Dis. 1993 Nov;52(11):795-800. doi: 10.1136/ard.52.11.795. Ann Rheum Dis. 1993. PMID: 8250611 Free PMC article.
-
Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4.Arthritis Rheum. 1982 Feb;25(2):161-7. doi: 10.1002/art.1780250208. Arthritis Rheum. 1982. PMID: 7066047
-
Differential reactivity of rheumatoid synovial cells and serum rheumatoid factors to human immunoglobulin G subclasses 1 and 3 and their CH3 domains in rheumatoid arthritis.Arthritis Rheum. 1987 May;30(5):489-97. doi: 10.1002/art.1780300502. Arthritis Rheum. 1987. PMID: 3593432
-
IgG3 reactive rheumatoid factor in rheumatoid arthritis: etiologic and pathogenic considerations.Autoimmunity. 1994;19(3):199-210. doi: 10.3109/08916939408995695. Autoimmunity. 1994. PMID: 7541651 Review.
-
[Measurement and comparison of the rheumatoid factors class IgG, IgM and IgA in chronic juvenile rheumatoid arthritis].An Esp Pediatr. 1989 Dec;31(6):554-8. An Esp Pediatr. 1989. PMID: 2698069 Review. Spanish.
Cited by
-
Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1.Cancer Immunol Immunother. 2025 May 24;74(7):216. doi: 10.1007/s00262-025-04078-0. Cancer Immunol Immunother. 2025. PMID: 40411581 Free PMC article.
-
Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.Front Immunol. 2018 Oct 29;9:2388. doi: 10.3389/fimmu.2018.02388. eCollection 2018. Front Immunol. 2018. PMID: 30420853 Free PMC article.
-
Novel mechanisms of action of the biologicals in rheumatic diseases.Clin Rev Allergy Immunol. 2014 Aug;47(1):6-16. doi: 10.1007/s12016-013-8359-x. Clin Rev Allergy Immunol. 2014. PMID: 23345026 Review.
-
Complement and autoimmunity.Immunol Res. 2013 Jul;56(2-3):477-91. doi: 10.1007/s12026-013-8422-y. Immunol Res. 2013. PMID: 23615835 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous